What Exosomes Are
Exosomes are nano-sized extracellular vesicles secreted by cells as a means of intercellular communication. They carry cargo including growth factors, cytokines, microRNA, and signalling proteins — modulating the recipient cell's behaviour.
In hair restoration, exosomes can deliver growth factor signals directly to hair follicle cells — potentially stimulating follicle regeneration, prolonging the anagen (growth) phase, and improving the cellular environment of the scalp.
What the Evidence Currently Shows
Exosome research in hair restoration is in its early stages. The published clinical evidence is promising but limited — most studies are small, use varying preparations, and have short follow-up periods.
What the existing evidence suggests is that exosome preparations can stimulate follicle activity, improve hair density, and increase hair shaft diameter in patients with androgenetic alopecia. Exosome therapy has become a meaningful adjunct in multi-modal hair restoration protocols.
DERIVE Hair Serum Exosomes at IN Eternity
DERIVE Hair Serum Exosomes is a topical exosome-enriched scalp treatment delivering growth factors and signalling molecules directly to the follicle environment. It is designed for use between H2LT laser sessions or as a standalone daily scalp treatment.
Dr. Sin Yong recommends DERIVE as a supportive element in a comprehensive hair restoration plan — alongside H2LT laser therapy and medical management. It is available directly from IN Eternity Clinic.
Setting Realistic Expectations
Exosome therapy is not a cure for androgenetic alopecia. It does not address the underlying DHT sensitivity that drives follicle miniaturisation. Its value is as an adjunct — improving the follicle environment and supporting the response to other treatments.
The most effective hair restoration outcomes come from combining medical management, laser therapy, and supportive treatments — in a plan designed and monitored by an experienced clinician.
How Exosomes Are Derived and Why Source Matters
Not all exosome preparations are equivalent. The therapeutic efficacy of an exosome product depends critically on the cellular source from which the exosomes are derived, the concentration of biologically active cargo they contain, and the stability of that cargo through the manufacturing and storage process.
Exosomes derived from stem cells — particularly human adipose-derived stem cells (hADSCs) or bone marrow mesenchymal stem cells — contain a particularly rich cargo of growth factors relevant to hair follicle function, including vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), and fibroblast growth factor (FGF). These growth factors are well-established stimulators of follicle anagen activity and scalp microvascularisation.
The DERIVE Hair Serum Exosomes used at IN Eternity is manufactured under controlled conditions with validated exosome concentration and growth factor content — ensuring that the product applied to the patient's scalp contains a therapeutically relevant dose of active cargo, not merely trace quantities in a carrier serum.
Integrating Exosomes Into a Complete Hair Restoration Plan
The most effective use of exosome therapy in clinical practice is as an integrated component of a multi-modal hair restoration plan — not as a standalone treatment. This reflects both the current evidence base and the biological logic of what exosomes do: they optimise the follicle environment and support the activity of medical and laser therapies, but they do not address the underlying hormonal driver of androgenetic alopecia.
A complete hair restoration plan at IN Eternity typically integrates medical therapy (finasteride and/or minoxidil as appropriate), H2LT laser sessions at 4–6 week intervals, DERIVE Hair Serum Exosomes applied at home between sessions, and periodic review to assess progress and adjust the plan. This integrated approach addresses the hormonal driver, the follicle's functional capacity, and the scalp microenvironment — all of which contribute to the degree of improvement achievable.
Exosomes do not fight the disease — they optimise the environment in which all the other treatments work.
- Exosomes are extracellular vesicles that carry growth factors, microRNA, and signalling proteins capable of modulating follicle cell behaviour
- Clinical evidence is promising but early-stage; exosome therapy is best used as an adjunct to medical and laser therapy, not a standalone treatment
- Not all exosome products are equivalent — source, concentration, and manufacturing quality determine therapeutic efficacy
- DERIVE Hair Serum Exosomes is used at IN Eternity for its validated growth factor content and stem cell-derived exosome quality
- The most effective hair restoration programmes integrate medical therapy, H2LT laser, and exosome support into a single coordinated plan
- Exosome therapy does not address the underlying DHT-driven follicle miniaturisation — medical therapy remains essential for androgenetic alopecia